Dr. Stacy K. Silvers, MD

Dr. Silvers practices at Aspire Allergy & Sinus in Austin, Texas.

Dr. Silvers' NPI, 1467629337, was assigned on May 10, 2008. Dr. Silvers graduated from UT Southwestern Medical Center in 2005. Dr. Silvers holds Texas license N8461.

Dr. Silvers' primary practice is Aspire Allergy & Sinus, at 5929 Balcones Dr, Austin, TX 78731 in Travis County. The practice phone is (512) 550-1800.

Dr. Silvers' primary practice is Aspire Allergy & Sinus in Austin, Texas. The medical group on file is Aspire Allergy & Sinus. Dmand AI also links Dr. Silvers to 5 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silvers practices, 5 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Silvers' primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Silvers is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Silvers' licenses on file in 7 states: Texas, Arizona, Colorado, New Mexico, Florida, Ohio and New York.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis and hives among the conditions Dr. Silvers treats.

CMS data shows 26,769 Medicare services from Dr. Silvers across 7 procedure codes in 2024, for 660 Medicare patients. Medicare paid $265,768 for them. Every service was in an office.

CMS counts 660 Medicare patients who saw Dr. Silvers in 2024. The largest group is 65 to 74, with 407 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Silvers' median patient age at 42, with 53% women.

In 2024, Dr. Silvers wrote 45 Medicare Part D claims for 26 patients. 84% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $98 in total drug cost. In 2022, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Silvers for performance year 2024, reported individually. CMS lists Dr. Silvers as offering telehealth.

Dmand AI links 8 papers to Dr. Silvers, published from 2016 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Allergens, Desensitization, Immunologic and Peanut Hypersensitivity. Dr. Silvers has published most often in Ann Allergy Asthma Immunol. Dr. Silvers' most frequent co-authors are Asaf Klein, MD, Robert W. Sugerman, MD and Richard Lawrence Wasserman, MD, PhD.

Dmand AI links Dr. Silvers to 1 clinical trial. Conditions studied include Conjunctivitis, Allergic and Rhinitis, Allergic, Seasonal.

CMS Open Payments shows 249 general payments to Dr. Silvers from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Genentech, Inc. paid the most, $17,077.

Dr. Silvers graduated from UT Southwestern Medical Center in 2005.

Dr. Silvers is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.